Scalable infrastructure for cloud based machine learning - Passive Income with Smart Investing

Product Description

Scalable infrastructure for cloud based machine learning ✌️【Risk Management】✌️Achieve up to 100% returns with ₹500. Start investing now for a brighter financial future!

Scalable infrastructure for cloud based machine learning ✌️【Risk Management】✌️Achieve up to 100% returns with ₹500. Start investing now for a brighter financial future!Hamps Bio, a pharmaceutical products supplier, which ran its IPO from December 13 to December 17 made its debut on the BSE SME platform on Friday (December 20) listing at Rs 96.90 over the issue price of Rs 51.

Scalable infrastructure for cloud based machine learning ✌️【Risk Management】✌️Start with ₹500 and let our expert-managed funds drive your profits up to 100% monthly!The shares of the company debuted at a premium of 90 per cent on the BSE SME platform.Hours before the official listing of the company on the Indian bourses, the GMP of Hamps BioIPOwas trading at Rs 60, with an estimated listing of Rs 111 per share, marking a 117.65 per cent gain in the greymarket, an unofficial marketplace to trade shares.The SME public issue, garnered a 1,057 times subscription.

Scalable infrastructure for cloud based machine learning ✌️【Risk Management】✌️Start small with ₹500 and enjoy huge returns. AI-driven investment for fast growth!The retail category lead the charge, with subscriptions soaring 1,342.04 times, while non-institutional investors (NII) subscribed 758.27 times.Also Read:DAM Capital Advisors IPO 2024 Live Updates: Check IPO price band, subscription status, GMP price, and other detailsHamps Bio IPO consisted entirely of a fresh issue of 12.2 lakh shares, with an aim of raising Rs 6.Scalable infrastructure for cloud based machine learning ✌️【Risk Management】✌️₹500 to unlock the potential for massive monthly earnings. Join now!